#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer limited stage Fragile X syndrome Prodromal Alzheimer's disease Nephropathy Progressive multifocal leukoencephalopathy Retinopathy of prematurity Primitive neuroectodermal tumour Hereditary spastic paraplegia Glioma Hormone-dependent prostate cancer Dupuytren's contracture Congenital megacolon Autoimmune myositis Turner's syndrome Non-Hodgkin's lymphoma unspecified histology aggressive recurrent More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia – Diagnostics Idiopathic pulmonary fibrosis – Trials in Disease Angiosarcoma – Basic Information Kearns-Sayre syndrome – Life with Disease Alexander disease Burkitt’s lymphoma Angiosarcoma – Diagnostics Mast cell activation syndrome – Trials in Disease Chondrosarcoma – Life with Disease Lymphangioma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cyanocobalamin Repotrectinib Sodium Valproate Zagociguat FLUORIDE Kan-101 FERUMOXTRAN-10 SAR444336 Rilpivirine Hydrochloride Deupirfenidone Teverelix Vinorelbine Nefopam Hydrochloride Ribonucleic Acid K10 GS-1720 M-(18F)-Fluorobenzylguanidine Blu-222 VHB937 Piperacillin Monohydrate Clofutriben More therapies…

    Learn about Your Condition

    Hyperadrenocorticism Anal fistula Pterygium Infection Spinal muscular atrophy Asymptomatic HIV infection Herpes simplex meningitis Elderly Metastases to biliary tract Myeloproliferative neoplasm Back pain Altered state of consciousness Large cell lung cancer Microscopic polyangiitis Squamous cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Osteoarthritis

  • Study on the Effects of LNA043 for Patients with Knee Osteoarthritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Lna043
    Czechia Denmark Estonia Poland Spain

  • Study on the Effects of KBP-336 and Paracetamol for Obese Patients with Knee Osteoarthritis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Kbp-336
    • Paracetamol
    Czechia Denmark Poland Romania

  • Study Comparing Allogeneic and Autologous Mesenchymal Stem Cells with Hyaluronic Acid for Patients with Knee Osteoarthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Allogeneic Adult Human Mesenchymal Stem Cells Ex-Vivo Expanded
    • Autologous Bone Marrow-Derived Mesenchymal Stem Cells
    • Sodium Hyaluronate
    Spain

  • Study on the Safety of RTX-GRT7039 and Ropivacaine Hydrochloride Injections for Patients with Moderate to Severe Knee Osteoarthritis Pain

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Resiniferatoxin
    • Ropivacaine Hydrochloride
    Bulgaria Poland Romania

  • Study of methotrexate compared to placebo for treating pain in patients with erosive hand osteoarthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Methotrexate
    • Placebo
    Norway

  • Study on the Effects of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Patients with Knee Osteoarthritis

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded
    • Sodium Chloride
    Denmark
Previous Page
1 … 5 6 7 8 9 10
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!